Arcutis Biotherapeutics, Inc.
USD27.97
+0.44 (+1.60%)
CEO
Todd Franklin Watanabe
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.50
Prev. Close
$27.53
Day Low
$27.50
Day High
$28.03
52W Low
$13.70
52W High
$31.77
Market Cap
$3.50B
Volume
0.29M
| 21,486 |
| $27.78 |
| 17 Jul 2026 | Peetz Christopher | director | A-Award | Acquired | 13,010 | $27.78 |
| 17 Jul 2026 | Peetz Christopher | director | Disposed | 0 | $0.00 |
| 17 Jul 2026 | Welgus Howard G. | director | M-Exempt | Acquired | 822 | $6.52 |
| 17 Jul 2026 | Welgus Howard G. | director | M-Exempt | Acquired | 1,019 | $7.51 |
| 17 Jul 2026 | Welgus Howard G. | director | M-Exempt | Acquired | 2,255 | $8.63 |
| 17 Jul 2026 | Welgus Howard G. | director | S-Sale | Disposed | 4,730 | $26.91 |
| 17 Jul 2026 | Welgus Howard G. | director | M-Exempt | Disposed | 822 | $6.52 |
| 17 Jul 2026 | Welgus Howard G. | director | M-Exempt | Disposed | 1,019 | $7.51 |
| $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Jan 2026 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 15 Oct 2023 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 19 May 2023 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 22 Jul 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |